April 11 (Reuters) - TESARO Inc:
* TESARO AND MEDISON ENTER INTO EXCLUSIVE DISTRIBUTION AGREEMENT TO COMMERCIALIZE ZEJULA® IN ISRAEL
* MEDISON WILL HAVE EXCLUSIVE RIGHT TO COMMERCIALIZE ZEJULA IN ALL INDICATIONS, EXCLUDING PROSTATE CANCER, IN ISRAEL
* MEDISON TO ALSO BE RESPONSIBLE FOR ANY POTENTIAL PATIENT ACCESS PROGRAMS PRIOR TO REGULATORY APPROVAL Source text for Eikon: Further company coverage: